OncoMed Pharmaceuticals Inc (OMED) [Rocket]

Overview

OncoMed Pharmaceuticals Inc (OMED)

Add to portfolio

1m \| 3m \| 6m \| 1y \| 2y \| 5y \| 10y

Price:	$1.07			Metrics
OS:	38.7	M
Market cap:	$41.4	M		-18	% ROIC
Net cash:	$57.3	M		$1.48	per share
EV:

TTM Valuation
EBITDA
EBIT	($8.2)	M
EPS

Recent News + Filings (All items)

Date Filed	Type	Description
05/03/2019	15-12B	Form 15-12B - Securities registration termination [Section 12(b)]:
04/26/2019	SC 13D/A	BIOTECHNOLOGY VALUE FUND L P reports a 0% stake in OncoMed Pharmaceuticals, Inc.
04/24/2019	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
04/24/2019	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
04/24/2019	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
04/24/2019	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
04/24/2019	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14	Dec-31-13	Dec-31-12	Dec-31-11
Revenues	98.9	117.3	153.8	25.9	39.6	37.8	24.7	31.4
Revenue growth	-15.7%	-23.7%	493.7%	-34.5%	4.7%	53.1%	-21.4%	77.3%
Cost of goods sold	0.0	0.0	0.0	-111.5	-90.3	-61.8	-47.2	-46.8
Gross profit	98.9	117.3	153.8	137.4	129.9	99.6	71.9	78.2
Gross margin	100.0%	100.0%	100.0%	530.6%	328.4%	263.7%	291.3%	249.1%
Research and development	34.4	59.8	109.7	92.9	76.4	50.0	39.9	40.1
General and administrative	18.2	16.8	18.8	18.6	13.8	11.6	7.2	6.6
EBIT	-8.2	-38.4	-103.3	-85.5	-50.5	-23.7	-22.2	-15.1
EBIT margin	-8.3%	-32.7%	-67.2%	-330.1%	-127.6%	-62.9%	-89.9%	-48.0%
Pre-tax income	-8.5	-40.1	-103.1	-85.4	-50.5	-24.1	-22.2	-15.0
Income taxes	-0.4	-1.1	0.0	0.0	-0.5	1.9	0.0	0.0
Tax rate	4.5%	2.7%			1.0%		0.0%	0.0%
Net income	-8.1	-39.1	-103.1	-85.4	-50.0	-26.1	-22.2	-15.0
Net margin	-8.2%	-33.3%	-67.1%	-329.8%	-126.4%	-69.0%	-90.1%	-47.9%

Diluted EPS	($0.21)	($1.04)	($3.14)	($2.84)	($1.69)	($1.93)	($21.30)	($15.40)
Shares outstanding (diluted)	38.4	37.6	32.9	30.0	29.7	13.5	1.0	1.0

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy